Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 16/2023

17.08.2023 | Research

Risk factors for surgical compliance and impact on the survival of patients with glioma: a population-based propensity score-matched study

verfasst von: Aifeng He, Leiming Xu, Xudong Yang, Zhou Gu, Yong Cai, Hai Zhou

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 16/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To comprehensively analyze the impact of surgical compliance on the survival of patients with glioma and to explore the factors that influence surgical compliance.

Methods

Clinical data of patients with glioma between 2004 and 2018 were collected from the Surveillance, Epidemiology, and End Results (SEER) database. Kaplan–Meier curves and Cox regression were used to analyze the effect of surgical compliance on overall survival (OS) and disease-specific survival (DSS). Multivariate Cox regression was used to select the prediction variables and construct the nomograms. The predictive power of these models was assessed using Harell’s consistency index (C-index), decision curve analysis (DCA), receiver operating characteristic (ROC) curves, and calibration curves. Multivariate logistic regression was performed to analyze the related variables of surgical compliance, and 1:1 propensity score matching (PSM) was applied to evaluate the validity of the results of patients with favorable and poor surgical compliance.

Results

Among the 47,573 eligible glioma patients recommended for surgery, 46,380 (97.5%) were in the surgical compliance group, while 1193 (2.5%) were in the noncompliance group. Surgical compliance was an independent prognostic factor for glioma patients, as indicated by multivariate Cox regression analysis that patients with surgical compliance had worse OS (hazard ratio [HR] 1.924; 95% confidence interval [CI] 1.800–2.056, p < 0.001) and DSS (HR 1.718; 95% CI 1.592–1.853, p < 0.001) in comparison to those without surgical compliance. A nomogram was developed and internally validated to be able to predict glioma prognosis. The nomogram can well predict patients’ OS (C-index: 0.745) and DSS (C-index: 0.744). ROC curve, DCA curve, and calibration curve were applied to further assess the accuracy of the nomogram. Poor surgical compliance was found to be related to older age, female gender, tumor diameter, grade II or higher, poor grading, tumor location in the cerebellum and brainstem, and low household income.

Conclusion

Surgical compliance is an independent prognostic factor for predicting the OS and DSS of patients with glioma, and good surgical compliance was significantly related to good survival.
Literatur
Zurück zum Zitat Adesunkanmi AR, Lawal OO, Adelusola KA, Durosimi MA (2006) The severity, outcome and challenges of breast cancer in Nigeria. Breast 15(3):399–409CrossRefPubMed Adesunkanmi AR, Lawal OO, Adelusola KA, Durosimi MA (2006) The severity, outcome and challenges of breast cancer in Nigeria. Breast 15(3):399–409CrossRefPubMed
Zurück zum Zitat Allen JC, Siffert J, Hukin J (1998) Clinical manifestations of childhood ependymoma: a multitude of syndromes. Pediatr Neurosurg 28(1):49–55CrossRefPubMed Allen JC, Siffert J, Hukin J (1998) Clinical manifestations of childhood ependymoma: a multitude of syndromes. Pediatr Neurosurg 28(1):49–55CrossRefPubMed
Zurück zum Zitat Benesch M, Mynarek M, Witt H, Warmuth-Metz M, Pietsch T, Bison B, Pfister SM, Pajtler KW, Kool M, Schüller U, Pietschmann K, Juhnke BO, Tippelt S, Fleischhack G, Schmid I, Kramm CM, Vorwerk P, Beilken A, Classen CF, Hernáiz Driever P, Kropshofer G, Imschweiler T, Lemmer A, Kortmann RD, Rutkowski S, von Hoff K (2019) Newly diagnosed metastatic intracranial ependymoma in children: frequency, molecular characteristics, treatment, and outcome in the prospective HIT series. Oncologist 24(9):e921–e929CrossRefPubMedPubMedCentral Benesch M, Mynarek M, Witt H, Warmuth-Metz M, Pietsch T, Bison B, Pfister SM, Pajtler KW, Kool M, Schüller U, Pietschmann K, Juhnke BO, Tippelt S, Fleischhack G, Schmid I, Kramm CM, Vorwerk P, Beilken A, Classen CF, Hernáiz Driever P, Kropshofer G, Imschweiler T, Lemmer A, Kortmann RD, Rutkowski S, von Hoff K (2019) Newly diagnosed metastatic intracranial ependymoma in children: frequency, molecular characteristics, treatment, and outcome in the prospective HIT series. Oncologist 24(9):e921–e929CrossRefPubMedPubMedCentral
Zurück zum Zitat Doll KM, Rademaker A, Sosa JA (2018) Practical guide to surgical data sets: surveillance, epidemiology, and end results (SEER) database. JAMA Surg 153(6):588–589CrossRefPubMed Doll KM, Rademaker A, Sosa JA (2018) Practical guide to surgical data sets: surveillance, epidemiology, and end results (SEER) database. JAMA Surg 153(6):588–589CrossRefPubMed
Zurück zum Zitat Hou Z, Luo D, Luo H, Hui Q, Xu Y, Lin X, Xu Z (2023) Co-expression prognostic-related genes signature base on propofol and sevoflurane anesthesia predict prognosis and immunotherapy response in glioblastoma. Ann Med 55(1):778–792CrossRefPubMedPubMedCentral Hou Z, Luo D, Luo H, Hui Q, Xu Y, Lin X, Xu Z (2023) Co-expression prognostic-related genes signature base on propofol and sevoflurane anesthesia predict prognosis and immunotherapy response in glioblastoma. Ann Med 55(1):778–792CrossRefPubMedPubMedCentral
Zurück zum Zitat Jakola AS, Myrmel KS, Kloster R, Torp SH, Lindal S, Unsgård G et al (2012) Comparison of a strategy favoring early surgical resection versus a strategy favoring watchful waiting in low-grade gliomas. JAMA 308:1881–1888CrossRefPubMed Jakola AS, Myrmel KS, Kloster R, Torp SH, Lindal S, Unsgård G et al (2012) Comparison of a strategy favoring early surgical resection versus a strategy favoring watchful waiting in low-grade gliomas. JAMA 308:1881–1888CrossRefPubMed
Zurück zum Zitat Kiserud T, Benachi A, Hecher K et al (2018) The World Health Organization fetal growth charts: concept, findings, interpretation, and application. Am J Obstet Gynecol 218(2S):S619–S629CrossRefPubMed Kiserud T, Benachi A, Hecher K et al (2018) The World Health Organization fetal growth charts: concept, findings, interpretation, and application. Am J Obstet Gynecol 218(2S):S619–S629CrossRefPubMed
Zurück zum Zitat Lah TT, Novak M, Breznik B (2020) Brain malignancies: glioblastoma and brain metastases. Semin Cancer Biol 60:262–273CrossRefPubMed Lah TT, Novak M, Breznik B (2020) Brain malignancies: glioblastoma and brain metastases. Semin Cancer Biol 60:262–273CrossRefPubMed
Zurück zum Zitat Liu G, Xu M, Gao T, Xu L, Zeng P, Bo H, Li F, Zhang W, Wang Z (2019) Surgical Compliance and Outcomes in Gastric Cancer: a population-based cohort study. J Cancer 10(4):779–788CrossRefPubMedPubMedCentral Liu G, Xu M, Gao T, Xu L, Zeng P, Bo H, Li F, Zhang W, Wang Z (2019) Surgical Compliance and Outcomes in Gastric Cancer: a population-based cohort study. J Cancer 10(4):779–788CrossRefPubMedPubMedCentral
Zurück zum Zitat Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Deimling A, Ellison DW (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23(8):1231–1251CrossRefPubMedPubMedCentral Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Deimling A, Ellison DW (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23(8):1231–1251CrossRefPubMedPubMedCentral
Zurück zum Zitat Luo J, Pan M, Mo K, Mao Y, Zou D (2023) Emerging role of artificial intelligence in diagnosis, classification and clinical management of glioma. Semin Cancer Biol 91:110–123CrossRefPubMed Luo J, Pan M, Mo K, Mao Y, Zou D (2023) Emerging role of artificial intelligence in diagnosis, classification and clinical management of glioma. Semin Cancer Biol 91:110–123CrossRefPubMed
Zurück zum Zitat Ma R, Taphoorn MJB, Plaha P (2021) Advances in the management of glioblastoma. J Neurol Neurosurg Psychiatry 92(10):1103–1111CrossRefPubMed Ma R, Taphoorn MJB, Plaha P (2021) Advances in the management of glioblastoma. J Neurol Neurosurg Psychiatry 92(10):1103–1111CrossRefPubMed
Zurück zum Zitat McKinnon C, Nandhabalan M, Murray SA et al (2021) Glioblastoma: clinical presentation, diagnosis, and management. BMJ 374:n1560CrossRefPubMed McKinnon C, Nandhabalan M, Murray SA et al (2021) Glioblastoma: clinical presentation, diagnosis, and management. BMJ 374:n1560CrossRefPubMed
Zurück zum Zitat Montero D, Madsen K, Meinild-Lundby AK, Edin F, Lundby C (2018) Sexual dimorphism of substrate utilization: differences in skeletal muscle mitochondrial volume density and function. Exp Physiol 103(6):851–859CrossRefPubMed Montero D, Madsen K, Meinild-Lundby AK, Edin F, Lundby C (2018) Sexual dimorphism of substrate utilization: differences in skeletal muscle mitochondrial volume density and function. Exp Physiol 103(6):851–859CrossRefPubMed
Zurück zum Zitat Olubajo F, Thorpe A, Davis C, Sinha R, Crofton A, Mills SJ, Williams M, Jenkinson MD, Price SJ, Watts C, Brodbelt AR (2022) Tumour treating fields in glioblastoma: is the treatment tolerable, effective, and practical in UK patients? Br J Neurosurg 36(6):770–776CrossRefPubMed Olubajo F, Thorpe A, Davis C, Sinha R, Crofton A, Mills SJ, Williams M, Jenkinson MD, Price SJ, Watts C, Brodbelt AR (2022) Tumour treating fields in glioblastoma: is the treatment tolerable, effective, and practical in UK patients? Br J Neurosurg 36(6):770–776CrossRefPubMed
Zurück zum Zitat Onken J, Staub-Bartelt F, Vajkoczy P, Misch M (2018) Acceptance and compliance of TTFields treatment among high grade glioma patients. J Neurooncol 139(1):177–184CrossRefPubMed Onken J, Staub-Bartelt F, Vajkoczy P, Misch M (2018) Acceptance and compliance of TTFields treatment among high grade glioma patients. J Neurooncol 139(1):177–184CrossRefPubMed
Zurück zum Zitat Ostrom QT, Bauchet L, Davis FG, Deltour I, Fisher JL, Langer CE, Pekmezci M, Schwartzbaum JA, Turner MC, Walsh KM, Wrensch MR, Barnholtz-Sloan JS (2014) The epidemiology of glioma in adults: a “state of the science” review. Neuro Oncol 16(7):896–913CrossRefPubMedPubMedCentral Ostrom QT, Bauchet L, Davis FG, Deltour I, Fisher JL, Langer CE, Pekmezci M, Schwartzbaum JA, Turner MC, Walsh KM, Wrensch MR, Barnholtz-Sloan JS (2014) The epidemiology of glioma in adults: a “state of the science” review. Neuro Oncol 16(7):896–913CrossRefPubMedPubMedCentral
Zurück zum Zitat Rigamonti A, Simonetti G, Silvani A et al (2021) Adult brainstem glioma: a multicentre retrospective analysis of 47 Italian patients. Neurol Sci 42(5):1879–1886CrossRefPubMed Rigamonti A, Simonetti G, Silvani A et al (2021) Adult brainstem glioma: a multicentre retrospective analysis of 47 Italian patients. Neurol Sci 42(5):1879–1886CrossRefPubMed
Zurück zum Zitat Shan Y, Ding Z, Cui Z, Chen A (2023) Incidence, prognostic factors and a nomogram of cervical cancer with distant organ metastasis: a SEER-based study. J Obstet Gynaecol 43(1):2181690CrossRefPubMed Shan Y, Ding Z, Cui Z, Chen A (2023) Incidence, prognostic factors and a nomogram of cervical cancer with distant organ metastasis: a SEER-based study. J Obstet Gynaecol 43(1):2181690CrossRefPubMed
Zurück zum Zitat Stessin AM, Sherr DL (2011) Demographic disparities in patterns of care and survival outcomes for patients with resected gastric adenocarcinoma. Cancer Epidemiol Biomarkers Prev 20:223–233CrossRefPubMed Stessin AM, Sherr DL (2011) Demographic disparities in patterns of care and survival outcomes for patients with resected gastric adenocarcinoma. Cancer Epidemiol Biomarkers Prev 20:223–233CrossRefPubMed
Zurück zum Zitat Tavallaii A, Meybodi KT, Nejat F, Habibi Z (2023) Current status of research on targeted therapy against central nervous system tumors in low- and lower-middle-income countries. World Neurosurg 12(174):74–80CrossRef Tavallaii A, Meybodi KT, Nejat F, Habibi Z (2023) Current status of research on targeted therapy against central nervous system tumors in low- and lower-middle-income countries. World Neurosurg 12(174):74–80CrossRef
Zurück zum Zitat Wang S, Mao W, Wang Y, Shi X, Wang W, Dai L, Zhang W (2020) Surgical compliance and survival outcomes for patients with stage T1–2 non-small-cell lung cancer. Cancer Manag Res 19(12):3597–3610CrossRef Wang S, Mao W, Wang Y, Shi X, Wang W, Dai L, Zhang W (2020) Surgical compliance and survival outcomes for patients with stage T1–2 non-small-cell lung cancer. Cancer Manag Res 19(12):3597–3610CrossRef
Zurück zum Zitat Wang K, Gu Y, Ni J, Zhang H, Xie J, Xu T, Geng J, Mao W, Peng B (2021) Combination of total psoas index and albumin-globulin score for the prognosis prediction of bladder cancer patients after radical cystectomy: a population-based study. Front Oncol 11:724536CrossRefPubMedPubMedCentral Wang K, Gu Y, Ni J, Zhang H, Xie J, Xu T, Geng J, Mao W, Peng B (2021) Combination of total psoas index and albumin-globulin score for the prognosis prediction of bladder cancer patients after radical cystectomy: a population-based study. Front Oncol 11:724536CrossRefPubMedPubMedCentral
Zurück zum Zitat Wang GM, Cioffi G, Patil N, Waite KA, Lanese R, Ostrom QT, Kruchko C, Berens ME, Connor JR, Lathia JD, Rubin JB, Barnholtz-Sloan JS (2022) Importance of the intersection of age and sex to understand variation in incidence and survival for primary malignant gliomas. Neuro Oncol 24(2):302–310CrossRefPubMed Wang GM, Cioffi G, Patil N, Waite KA, Lanese R, Ostrom QT, Kruchko C, Berens ME, Connor JR, Lathia JD, Rubin JB, Barnholtz-Sloan JS (2022) Importance of the intersection of age and sex to understand variation in incidence and survival for primary malignant gliomas. Neuro Oncol 24(2):302–310CrossRefPubMed
Zurück zum Zitat Withrow DR, Nicholson BD, Morris EJA, Wong ML, Pilleron S (2023) Age-related differences in cancer relative survival in the United States: a SEER-18 analysis. Int J Cancer 152(11):2283–2291CrossRefPubMed Withrow DR, Nicholson BD, Morris EJA, Wong ML, Pilleron S (2023) Age-related differences in cancer relative survival in the United States: a SEER-18 analysis. Int J Cancer 152(11):2283–2291CrossRefPubMed
Zurück zum Zitat Yang P, Wang Y, Peng X, You G, Zhang W, Yan W et al (2013) Management and survival rates in patients with glioma in China (2004–2010): a retrospective study from a single-institution. J Neuro-Oncol 113(2):259–266CrossRef Yang P, Wang Y, Peng X, You G, Zhang W, Yan W et al (2013) Management and survival rates in patients with glioma in China (2004–2010): a retrospective study from a single-institution. J Neuro-Oncol 113(2):259–266CrossRef
Zurück zum Zitat Yang Z, Zhao C, Zong S, Piao J, Zhao Y, Chen X (2023) A review on surgical treatment options in gliomas. Front Oncol 16(13):1088484CrossRef Yang Z, Zhao C, Zong S, Piao J, Zhao Y, Chen X (2023) A review on surgical treatment options in gliomas. Front Oncol 16(13):1088484CrossRef
Zurück zum Zitat Zhang D, Li H, Jia W (2023) Exploration of the prognostic value of the resection of adult brainstem high-grade glioma based on competing risk model, propensity score matching, and conditional survival rate. Neurol Sci 44(5):1755–1764CrossRefPubMedPubMedCentral Zhang D, Li H, Jia W (2023) Exploration of the prognostic value of the resection of adult brainstem high-grade glioma based on competing risk model, propensity score matching, and conditional survival rate. Neurol Sci 44(5):1755–1764CrossRefPubMedPubMedCentral
Zurück zum Zitat Zheng BS, Wang SD, Zhang JY, Ge CG (2023) Incidence, prognostic factors, and survival of patients with renal cancer: a population-based study. J Invest Surg 36(1):2197506CrossRefPubMed Zheng BS, Wang SD, Zhang JY, Ge CG (2023) Incidence, prognostic factors, and survival of patients with renal cancer: a population-based study. J Invest Surg 36(1):2197506CrossRefPubMed
Zurück zum Zitat Zore T, Palafox M, Reue K (2018) Sex differences in obesity, lipid metabolism, and inflammation-A role for the sex chromosomes? Mol Metab 15:35–44CrossRefPubMedPubMedCentral Zore T, Palafox M, Reue K (2018) Sex differences in obesity, lipid metabolism, and inflammation-A role for the sex chromosomes? Mol Metab 15:35–44CrossRefPubMedPubMedCentral
Metadaten
Titel
Risk factors for surgical compliance and impact on the survival of patients with glioma: a population-based propensity score-matched study
verfasst von
Aifeng He
Leiming Xu
Xudong Yang
Zhou Gu
Yong Cai
Hai Zhou
Publikationsdatum
17.08.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 16/2023
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-023-05261-5

Weitere Artikel der Ausgabe 16/2023

Journal of Cancer Research and Clinical Oncology 16/2023 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.